CrossrefInfokarte
Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients
Endocrine Journal · 2026 · 73 (9) · 1045-1054
DOI: 10.1507/endocrj.ej25-0629 ↗Abstract
Kein Abstract verfügbar.
EUVIMED